Table 2.
Locomotor Activity in Naïve Marchigian Sardinian Alcohol-Preferring Rats Treated With Buprenorphine, UFP-101, or Their Combination
| Treatment | Time Resting (min) |
Distance Traveled (cm) |
||
|---|---|---|---|---|
| Pretreatment | Treatment | Pretreatment | Treatment | |
| Veh + Veh | 23.6 ± 1.4 | 23 ± 1.4 | 3717.6 ± 1232.5 | 3859.6 ± 972 |
| UFP + Veh | 22.9 ± 1.2 | 23.7 ± 1.3 | 3618.6 ± 615.5 | 3050.3 ± 715 |
| Veh + Bup | 23.6 ± 1 | 24.2 ± .7 | 3575 ± 709.1 | 2997.6 ± 393.2 |
| UFP + Bup | 24.6 ± 1.5 | 21.9 ± .2 | 3415 ± 1008.3 | 3961 ± 706.3 |
UFP-101 (20.0 μg/rat, intracerebroventricular was injected twice, 95 and 15 min before placing the animal into the open-field chambers. Buprenorphine (3.0 mg/kg, intraperitoneal) was given 90 min before placing the animal into the open-field chambers. Each value represents the mean (±SEM) of six subjects. Veh, vehicle; UFP, UFP-101; Bup, Buprenorphine.